Result page for
Testosterone propionate:
Testosterone propionate
General information:
Withdrawal information:
| Withdrawn due to drug safety reasons: | No |
| First approved: |
1974 |
| First withdrawn: |
1982 |
Side-effects:
| Total reported cases (submitted by medical professionals)
with Testosterone propionate as primary suspect: |
3 |
Reported final outcomes:
| Hospitalization (initial or prolonged): |
2 |
| Life-Threatening condition: |
1 |
| Intervention required to
prevent permanent impairment/damage: |
1 |
| Death: |
1 |
Reported side-effects:
| Side-effect |
Case number |
| VENTRICULAR TACHYCARDIA | 1 |
| VENTRICULAR HYPOKINESIA | 1 |
| VENTRICULAR HYPERTROPHY | 1 |
| RESPIRATORY FAILURE | 1 |
| POST PROCEDURAL COMPLICATION | 1 |
| PENIS DISORDER | 1 |
| Injection site swelling | 1 |
| Injection site pain | 1 |
| DRUG WITHDRAWAL SYNDROME | 1 |
| DERMAL CYST | 1 |
| CARDIAC ARREST | 1 |
| AORTIC STENOSIS | 1 |
| ANAESTHETIC COMPLICATION CARDIAC | 1 |
Filtered ChEMBL targets:
| Target UniProtKB ID |
Activity in nm |
Target Name |
Target gene |
| P02545 |
7.9 |
Prelamin-A/C |
LMNA_HUMAN |
| P10275 |
0.25 |
Androgen receptor |
ANDR_HUMAN |
Toxicity information:
|
Toxicity class: |
4 |
| Toxicity type: |
N/A |
| LD50: |
1000 mg/kg |
External links: